Log on / register
Feedback | Support | My details
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C
Breast Cancer Res 2008, 10:R53
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%


 Review
Breast cancer stem cells: tools and models to rely on
Charafe-Jauffret E, Ginestier C, Birnbaum D
BMC Cancer 2009, 9:202 (25 June 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
2.
36%36%

 Viewpoint
Number crunching in the cancer stem cell market
Alison MR, Islam S, Lim SML
Breast Cancer Research 2009, 11:302 (24 April 2009)
[Full text] [PubMed Central] [PubMed] [Related articles]
3.
36%36%


 Editorial
Breast cancer stem cell markers the rocky road to clinical applications
Dontu G
Breast Cancer Research 2008, 10:110 (15 September 2008)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
4.
36%36%


 Review
Breast cancer stem cells: implications for therapy of breast cancer
Morrison BJ, Schmidt CW, Lakhani SR, Reynolds BA, Lopez JA
Breast Cancer Research 2008, 10:210 (22 July 2008)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.